MobiHealth News June 23, 2023
The company also added two new members to its board of directors and a new senior vice president for Medicare Advantage.
Health technology company Aledade announced it scored a whopping $260 million in Series F funding.
Lightspeed Venture Partners led the round with participation from Venrock, Avidity Partners, OMERS Growth Equity and Fidelity Management & Research Company.
According to Bloomberg, the latest funding round brings the company’s valuation to $3.5 billion, aiding the company in achieving unicorn status.
Dr. David Blumenthal, former president of the Commonwealth Fund and United States National Coordinator for Health Information Technology, and Paul Hennessy, CEO of Shutterstock, will join Aledade’s board of directors.
Dr. Efrem Castillo, who previously served as senior vice president...
Today's Sponsors
Today's Sponsor